Business News
AI Drug Discovery Pulls in Fresh Capital as GV Backs Singapore’s Engine
The investment underscores a sharp resurgence in global AI-biotech funding, though startups still face the high-stakes clinical challenge of moving AI-discovered therapies successfully through human trials.